Species differences in the hepatic biotransformation of zearalenone

被引:184
作者
Malekinejad, H. [1 ]
Maas-Bakker, R. [1 ]
Fink-Gremmels, J. [1 ]
机构
[1] Univ Utrecht, Fac Vet Med, Dept Vet Pharmacol Pharm & Toxicol, NL-3508 TD Utrecht, Netherlands
关键词
zearalenone; alpha-zearalenol (alpha-ZOL); beta-zearalenol (beta-ZOL); biotransformation; glucuronidation;
D O I
10.1016/j.tvjl.2005.03.004
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Zearalenone (ZEA), a Fusarium toxin, is frequently found in animal feed materials. It is known to exert oestrogenic effects in all animals tested but susceptibility varies between species, possibly reflecting differences in the metabolic processing of ZEA, which predominantly involves hydroxylations, assumed to be catalysed by 3 alpha- and 3 beta- hydroxysteroid dehydrogenases, as well as conjugation with glucuronic acid. In this study, the biotransformation of ZEA by hepatic subcellular fractions of various domestic animals was investigated and compared to the rat. Notable inter-species differences in terms of the rate of absolute and relative metabolite production in the different subcellular fractions were identified. The highest amount of a-zearalenol (alpha-ZOL) was produced by pig hepatic microsomes (V-max = 795.8 +/- 122.7 pmol/mg/min), whereas in chicken microsomes the highest amounts of beta-zearalenol (beta-ZOL) (V-max = 1524 +/- 29.7 pmol/mg/min) could be measured. Except for sheep and cattle, the efficiency of alpha-ZOL production (expressed as the ratio of apparent V-max/k(m),) was higher in the microsomal fraction compared to the post-mitochondrial fraction. In contrast, the apparent efficiency of beta-ZOL production was high in pigs, cattle, chickens and rats, but very low in sheep. Conjugation of ZEA with glucuronic acid was investigated, and the results indicated significant inter-species differences in the rate of glucuronidation, which was saturable at low concentrations in all species tested, except pigs. The significant differences between the percentages of glucuronidation of ZEA, alpha-ZOL, and beta-ZOL suggest not only differences in the affinity of the individual substrate, but might also indicate the presence of different isoforms of uridine diphosphate glucuronyl transferases (UDPGTs). The results are of clinical relevance, as they contribute to the understanding of the species-specific susceptibility towards exposure to ZEA. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 34 条
[1]   DETERMINATION OF NONCONJUGATED AND CONJUGATED STEROID-LEVELS IN PLASMA AND PROSTATE AFTER SEPARATION ON C-18 COLUMNS [J].
BELANGER, A ;
COUTURE, J ;
CARON, S ;
ROY, R .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 595 :251-259
[2]   BILIARY-EXCRETION AND ENTEROHEPATIC CYCLING OF ZEARALENONE IN IMMATURE PIGS [J].
BIEHL, ML ;
PRELUSKY, DB ;
KORITZ, GD ;
HARTIN, KE ;
BUCK, WB ;
TRENHOLM, HL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1993, 121 (01) :152-159
[3]  
BORIES GF, 1991, DRUG METAB DISPOS, V19, P140
[4]   MECHANISM OF FUSARIUM MYCOTOXIN ACTION IN MAMMARY-GLAND [J].
BOYD, PA ;
WITTLIFF, JL .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1978, 4 (01) :1-8
[5]   A sensitive zonagenetic assay for rapid in vitro assessment of estrogenic potency of xenobiotics and mycotoxins [J].
Celius, T ;
Haugen, TB ;
Grotmol, T ;
Walther, BT .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 (01) :63-68
[6]  
CHANG K, 1979, AM J VET RES, V40, P1260
[7]   3α-hydroxysteroid dehydrogenase in animal and human tissues [J].
Degtiar, WG ;
Kushlinsky, NE .
BIOCHEMISTRY-MOSCOW, 2001, 66 (03) :256-266
[8]  
ETIENNE M, 1982, J ANIM SCI, V55, P1
[9]   VETERINARY DRUGS - DISPOSITION, BIOTRANSFORMATION AND RISK-EVALUATION [J].
FINKGREMMELS, J ;
VANMIERT, ASJPAM .
ANALYST, 1994, 119 (12) :2521-2528
[10]   MEASUREMENT OF THE RELATIVE BINDING-AFFINITY OF ZEARALENONE, ALPHA-ZEARALENOL AND BETA-ZEARALENOL FOR UTERINE AND OVIDUCT ESTROGEN-RECEPTORS IN SWINE, RATS AND CHICKENS - AN INDICATOR OF ESTROGENIC POTENCIES [J].
FITZPATRICK, DW ;
PICKEN, CA ;
MURPHY, LC ;
BUHR, MM .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1989, 94 (02) :691-694